A carregar...
Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer’s Disease
BACKGROUND: ALZ-801 is an orally available, valine-conjugated prodrug of tramiprosate. Tramiprosate, the active agent, is a small-molecule β-amyloid (Aβ) anti-oligomer and aggregation inhibitor that was evaluated extensively in preclinical and clinical investigations for the treatment of Alzheimer’s...
Na minha lista:
Publicado no: | Clin Pharmacokinet |
---|---|
Main Authors: | , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer International Publishing
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5814546/ https://ncbi.nlm.nih.gov/pubmed/29063518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-017-0608-3 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|